INCY ▼ -2.8% - Incyte Corporation $INCY Povofortay® (povorcitinib) Approved in Europe as the First Once-Daily Oral Treatment for Adults with Moderate to Severe Hidradenitis Suppurativa 16-NOV-2026 04:31 PM ET